Manipulating the immune system for anti‐tumor responses and transplant tolerance via mixed hematopoietic chimerism
Authors:
- 1 June 2008
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 223 (1) , 334-360
Abstract
Summary: Stem cells (SCs) with varying potentiality have the capacity to repair injured tissues. While promising animal data have been obtained, allogeneic SCs and their progeny are subject to immune‐mediated rejection. Here, we review the potential of hematopoietic stem cells (HSCs) to promote immune tolerance to allogeneic and xenogeneic organs and tissues, to reverse autoimmunity, and to be used optimally to cure hematologic malignancies. We also review the mechanisms by which hematopoietic cell transplantation (HCT) can promote anti‐tumor responses and establish donor‐specific transplantation tolerance. We discuss the barriers to clinical translation of animal studies and describe some recent studies indicating how they can be overcome. The recent achievements of durable mixed chimerism across human leukocyte antigen barriers without graft‐versus‐host disease and of organ allograft tolerance through combined kidney and bone marrow transplantation suggest that the potential of this approach for use in the treatment of many human diseases may ultimately be realized.Keywords
This publication has 264 references indexed in Scilit:
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Acceleration of allograft failure by cytomegalovirusCurrent Opinion in Immunology, 2007
- Peripheral deletion of mature alloreactive B cells induced by costimulation blockadeProceedings of the National Academy of Sciences, 2007
- Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabineExperimental Hematology, 2007
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- An Essential Role for IFN-γ in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2007
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattleHeredity, 1951